NEW YORK (GenomeWeb News) — Assay Depot, a soon-to-be-launched online "marketplace for drug-discovery services," has signed up Nanostream as a service provider, the companies said today.
Assay Depot will allow customers to choose a particular assay, mail in test samples, and receive a data report "a few weeks later." The online shopping site will include "multiple service providers offering a wide range of drug-discovery services," the companies added.
Nanostream has developed assays for kinases, lipid-modifying enzymes, proteases, and cytochrome P450 enzymes.
“Bioassay support has increasingly become too labor-intensive and too time-consuming for drug discovery organizations, which has led researchers to outsource this costly function,” Nanostream COO Jonas Ekblom said in a statement.
Assay Depot offers "a virtual laboratory where researchers can conduct their drug-discovery programs," which streamlines the process for the customer and the service provider, he added.
Last week, Assay Depot said it raised $1.8 million in Series A financing, which it plans to use to launch its online service early next year.